Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luveris Efficacy Confirmation in Hypogonadotropic Hypogonadism
NCT00328926Phase 4Terminated
- Sponsor
- EMD Serono
- Start
- Mar 2006
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of lutropin alfa in hypogonadotropic hypogonadism (HH), sponsored by EMD Serono. Started Mar 2006; status: terminated.
02
Drugs
lutropin alfa
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT00328926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328926.